BIOMAT Database Logo BIOMAT Database Logo

[Treatment of chronic myelogenous leukemia with oral bis (3-mesyloxypropyl) amine p-toluenesulfonate]. 1972

M Hirano, and K Koie, and R Ono, and K Yamada

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000476 Alkanesulfonates Organic esters or salts of sulfonic acid derivatives containing an aliphatic hydrocarbon radical. Alkyl Sulfonates,Sulfonates, Alkyl
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D014105 Tosyl Compounds Toluenesulfonyl compounds with general formula CH3C6H4S(O2)R” widely used to block amino groups in the course of syntheses of drugs and other biologically active compounds. Toluenesulfonyl Compounds,Compounds, Toluenesulfonyl,Compounds, Tosyl

Related Publications

M Hirano, and K Koie, and R Ono, and K Yamada
[Studies on the No. 864-T (bis (3-mesyloxypropyl) amine p-toluensulfonate) therapy of chronic myelogenous leukemia and polycythemia vera (author's transl)].
January 1975, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Hirano, and K Koie, and R Ono, and K Yamada
Immunosuppressive and antitumor activities of N-methyl-bis(3-mesyloxypropyl)amine hydrochloride and bis(3-mesyloxypropyl)amine hydrochloride.
August 1970, Gan,
M Hirano, and K Koie, and R Ono, and K Yamada
Treatment of chronic myelogenous leukemia with 3,3'-iminodi-1-propanol, dimethanesulfonate (ester), p-toluenesulfonate (NSC-140117) given orally.
June 1972, Cancer chemotherapy reports,
M Hirano, and K Koie, and R Ono, and K Yamada
[Absorption, excretion, distribution and metabolism of bis(3-methylsulfonyloxypropyl)amine p-toluenesulfonate (864-T) in normal rats].
September 1974, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M Hirano, and K Koie, and R Ono, and K Yamada
On the effect of N-methyl-bis (3-mesyloxypropyl) amine hydroxychloride on Bacillus subtilis cells.
June 1975, The Journal of antibiotics,
M Hirano, and K Koie, and R Ono, and K Yamada
[Treatment of chronic myelogenous leukemia with oral dibromomannitol (author's transl)].
September 1973, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Hirano, and K Koie, and R Ono, and K Yamada
Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
October 1973, Gan,
M Hirano, and K Koie, and R Ono, and K Yamada
Distribution of N-methyl [14C]-bis (3-mesyloxypropyl)-amine hydrochloride and its metabolites in normal and tumor-bearing rats.
December 1968, Gan,
M Hirano, and K Koie, and R Ono, and K Yamada
Treatment of chronic myelogenous leukemia.
December 1980, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
M Hirano, and K Koie, and R Ono, and K Yamada
Treatment of chronic myelogenous leukemia.
August 1995, Seminars in oncology,
Copied contents to your clipboard!